Thermo Fisher

Thermo Fisher named a ‘Best Place to Work for LGBT Equality’

Monday, November 23, 2015

Thermo Fisher Scientific, based in Waltham, Mass., received a perfect score of 100 on the Human Rights Campaign’s annual 2016 Corporate Equality Index (CEI), making it a “Best Place to Work for LGBT Equality.” The CEI, a national benchmarking tool for lesbian, gay, bisexual and transgender workplace inclusion, provides an in-depth analysis and rating of large U.S. employers relevant to LGBT policies and practices.

[Read More]

Thermo Fisher Scientific opens facility in Singapore

Friday, November 20, 2015

Thermo Fisher Scientific has opened a new state-of-the-art GMP facility in Singapore. The company, which established its first clinical services facility there in 2001, said the move to the newly built facility will meet the growing demand for clinical supply services in the region. The new site will provide both regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies—from GMP storage, local labeling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies to returns management.

[Read More]

Thermo Fisher launches next-generation sequencing

Wednesday, September 9, 2015

Thermo Fisher Scientific has launched two next-generation sequencing (NGS) systems designed to deliver a comprehensive solution that simplifies targeted sequencing. Built upon Ion Torrent technology, the new Ion S5 and Ion S5 XL benchtop systems provide scientists with rapid, cost-effective and flexible platforms that can be scaled for all research areas, including inherited disorders, infectious agents, microbial identification and translational cancer research.

[Read More]

Thermo Fisher Scientific, CDC partner to accelerate global microbial identification

Friday, July 17, 2015

Through a partnership with the Special Bacteriology Reference Laboratory at the Centers for Disease Control and Prevention (CDC), Thermo Fisher Scientific has developed an advanced software solution that enables global public health laboratories to directly access the CDC’s MicrobeNet online virtual reference lab database. Now, researchers can more quickly identify microbial pathogens potentially at the root of global outbreaks without needing to refer to multiple databases by instead utilizing one curated by subject matter experts in the field.

[Read More]

Cord Blood Registry forms scientific and medical advisory board

Thursday, February 5, 2015

Cord Blood Registry (CBR) has announced the establishment of a scientific and medical advisory board (SMAB). Composed of internationally renowned stem cell experts, the SMAB will provide input and guidance to help advance CBR’s mission to expand the scope of newborn stem cell therapies that may be available to patients and their families. The founding members of the SMAB are Dr. Charles Cox, Dr. Mahendra Rao, Dr. Leslie Silberstein and Dr. Alan Trounson. Rao will be the inaugural chairman of the SMAB, and he also will be acting as CBR’s chief clinical and regulatory advisor.

[Read More]

AstraZeneca collaborates to use CRISPR technology

Friday, January 30, 2015

AstraZeneca has announced four research collaborations aimed at harnessing the power of CRISPR, a pioneering genome-editing technique, across its entire discovery platform in the company’s key therapeutic areas. The four research collaborations are with the Wellcome Trust Sanger Institute, Cambridge, U.K.; the Innovative Genomics Initiative, California; Thermo Fisher Scientific, Waltham, Mass.; and the Broad Institute/Whitehead Institute, Cambridge, Mass. The technology will allow AZ to identify and validate new drug targets in preclinical models that closely resemble human disease.

[Read More]

Diagnostics Development Hub to boost biomedical research in Singapore

Thursday, December 4, 2014

Singapore’s biomedical research sector received a major boost with the launch of a new Diagnostics Development (DxD) Hub. The DxD Hub aims to develop medical diagnostics as one part of the medical technologies industry, improve healthcare through development of diagnostic solutions and accelerate production of new diagnostics devices. Diagnostics is one of four innovation clusters shortlisted to be funded under the $200 million Innovation Cluster Program (ICP) launched Oct. 2013.

[Read More]